First Cosmic Organoid Villages™ Launch to Space Station, Advancing Research Toward ‘Clinical Trials in a Dish’
The National Stem Cell Foundation has launched its seventh mission to the International Space Station, featuring 'Cosmic Organoid Villages.' These experiments combine multiple patient cell lines into single organoids to better model neurodegenerative diseases like Parkinson's and Alzheimer's.
Why it matters
This research aims to accelerate drug discovery by creating more accurate disease models in microgravity, potentially leading to more effective clinical treatments.
NSCF Research Associate Maria Balaguer loads cryovials containing Cosmic Organoid Villages™ into a rack in preparation for launch on SpaceX CRS-35.
NSCF’s SpaceX CRS-35 mission patch designed by award-winning artist Gregory Manchess highlights the first-ever flight of Cosmic Organoid Villages™, combining multiple cell lines in a single organoid to mimic complex neurodegenerative diseases at the population level for better therapeutic targeting. Also featured are long-time mission partners Axiom Space and BioServe Space Technologies.
The National Stem Cell Foundation (NSCF), a leading funder of space-based brain organoid research to fight neurodegenerative conditions like Parkinson's, primary progressive multiple sclerosis (PPMS), and Alzheimer's, announced the launch of its seventh mission to the International Space Station (ISS) carrying the first Cosmic Organoid Villages.(tm)
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in